Table 1.
Milan System Diagnostic Category | No. of FNAs (% of Total) | No. of FNAs Followed by Resection | Histologic Correlation | RON (%) | ROM-H (%) | ROM-C (%) | ||
---|---|---|---|---|---|---|---|---|
Nonneoplastic | Benign Neoplasm | Malignant Neoplasm | ||||||
Nondiagnostic | 17 (16) | 5 | 2 | 3 | 0 | 60 | 0 | 0 |
Nonneoplastic | 54 (52) | 18 | 16 | 0 | 2 | 11 | 11 | 4 |
AUS | 4 (4) | 4 | 0 | 0 | 4 | 100 | 100 | 100 |
Benign neoplasm | 18 (17) | 18 | 0 | 17 | 1 | 100 | 6 | 6 |
SUMP | 3 (3) | 3 | 0 | 1 | 2 | 100 | 67 | 67 |
SM | 2 (2) | 2 | 0 | 0 | 2 | 100 | 100 | 100 |
Malignant | 6 (6) | 4 | 0 | 0 | 4 | 100 | 100 | 67 |
Total | 104 | 54 | 18 | 21 | 15 | N/A | N/A | N/A |
Abbreviations: FNA, fine‐needle aspiration; RON, risk of neoplam, ROM, risk of malignancy; ROM‐H, risk of malignancy based on histologic follow‐up; ROM‐C, risk of malignancy based on cytologic specimens; AUS, atypia of undetermined significance; SUMP, salivary gland neoplasm of uncertain malignant potential; SM, suspicious for malignancy.